BG108183A - Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles - Google Patents

Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles

Info

Publication number
BG108183A
BG108183A BG108183A BG10818303A BG108183A BG 108183 A BG108183 A BG 108183A BG 108183 A BG108183 A BG 108183A BG 10818303 A BG10818303 A BG 10818303A BG 108183 A BG108183 A BG 108183A
Authority
BG
Bulgaria
Prior art keywords
indolopyrrolocarbazoles
topoisomerase
sugar derivatives
selective cytotoxic
sugar
Prior art date
Application number
BG108183A
Other languages
Bulgarian (bg)
English (en)
Inventor
Edward H. Ruediger
Mark G. Saulnier
Francis Beaulieu
Carol Bachand
Neelakantan Balusubramanian
Byron H. Long
David B. Frennesson
Kurt Zimmerman
Narasimhulu B. Naidu
Karen Stoffan
Denis R. St.laurent
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of BG108183A publication Critical patent/BG108183A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BG108183A 2001-03-22 2003-09-18 Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles BG108183A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27804301P 2001-03-22 2001-03-22
PCT/US2002/008819 WO2002077255A1 (en) 2001-03-22 2002-03-22 Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles

Publications (1)

Publication Number Publication Date
BG108183A true BG108183A (en) 2004-07-30

Family

ID=23063451

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108183A BG108183A (en) 2001-03-22 2003-09-18 Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles

Country Status (22)

Country Link
US (1) US6855698B2 (no)
EP (1) EP1370673A4 (no)
JP (1) JP2004534006A (no)
KR (1) KR20030085035A (no)
CN (1) CN1509335A (no)
BG (1) BG108183A (no)
BR (1) BR0208322A (no)
CA (1) CA2441412A1 (no)
CZ (1) CZ20032876A3 (no)
EE (1) EE200300456A (no)
HR (1) HRP20030761A2 (no)
HU (1) HUP0400265A2 (no)
IL (1) IL157909A0 (no)
IS (1) IS6958A (no)
MX (1) MXPA03008589A (no)
NO (1) NO20034190L (no)
PL (1) PL368942A1 (no)
RU (1) RU2003131269A (no)
SK (1) SK12022003A3 (no)
WO (1) WO2002077255A1 (no)
YU (1) YU74103A (no)
ZA (1) ZA200307317B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2326459B1 (es) 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487925A (en) 1983-01-28 1984-12-11 Bristol-Myers Company Rebeccamycin and process for its preparation
US4552842A (en) 1983-01-28 1985-11-12 Bristol-Myers Company Process for producing rebeccamycin
US4567143A (en) 1984-09-04 1986-01-28 Bristol-Myers Company Process for preparing 4'-deschlororebeccamycin
US4785085A (en) 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
WO1989007105A1 (en) 1988-02-04 1989-08-10 Kyowa Hakko Kogyo Co., Ltd. Staurosporin derivatives
DE3803620A1 (de) 1988-02-06 1989-08-17 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE3924538A1 (de) 1989-07-25 1991-01-31 Goedecke Ag Indolocarbazol und dessen verwendung
US5618809A (en) 1989-12-14 1997-04-08 Schering Corporation Indolocarbazoles from saccharothrix aerocolonigenes copiosa subsp. nov SCC 1951 ATCC 53856
IL97233A (en) 1990-03-06 1995-03-30 Bristol Myers Squibb Co Analogs of rabamycin, their manufacture and pharmaceutical preparations containing them
US5478813A (en) 1990-05-11 1995-12-26 Banyu Pharmaceutical Co., Ltd. Antitumor substance BE-13793C derivatives
US5589365A (en) * 1991-11-29 1996-12-31 Banyu Pharmaceutical Co., Ltd. Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms
NZ245203A (en) 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
US5668271A (en) 1991-11-29 1997-09-16 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives
DE69331228D1 (en) 1992-09-21 2002-01-10 Kyowa Hakko Kogyo Kk Heilmittel für thrombozytopenia
FR2696465B1 (fr) 1992-10-02 1994-12-23 Adir Nouveaux dérivés d'ellipticine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
JP3603322B2 (ja) 1992-12-14 2004-12-22 萬有製薬株式会社 インドロピロロカルバゾール誘導体の製造法
US5468872A (en) 1993-09-16 1995-11-21 Cephalon, Inc. K-252a functional derivatives potentiate neurotrophin-3 for the treatment of neurological disorders
WO1995030682A1 (fr) 1994-05-09 1995-11-16 Banyu Pharmaceutical Co., Ltd. Derive d'indolopyrolocarbazole antitumoral
WO1996004293A1 (fr) 1994-08-02 1996-02-15 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazoles antitumoraux
US5475110A (en) 1994-10-14 1995-12-12 Cephalon, Inc. Fused Pyrrolocarbazoles
US5705511A (en) 1994-10-14 1998-01-06 Cephalon, Inc. Fused pyrrolocarbazoles
WO1997007081A2 (en) 1995-08-11 1997-02-27 Yale University Glycosylated indolocarbazole synthesis
JP2000516250A (ja) * 1996-08-22 2000-12-05 ブリストルーマイヤーズ スクイブ カンパニー インドロピロロカルバゾールの細胞毒性アミノ糖および関連する糖誘導体
CO4940430A1 (es) 1997-07-07 2000-07-24 Novartis Ag Compuestos policiclicos que contienen estaurosporina hidrogenada con propiedades farmacologicas convenientes y un efecto inhibidor sobre el crecimiento de las celulas tumorales
FR2801054B1 (fr) 1999-11-17 2003-06-13 Adir Nouveaux derives de 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo [3,4-c]carbazole et 12,13-(pyranosyl)-furo[3,4-c]indolo [2,3-a]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
HUP0400265A2 (hu) 2004-08-30
SK12022003A3 (sk) 2004-05-04
EP1370673A4 (en) 2006-08-09
EP1370673A1 (en) 2003-12-17
US6855698B2 (en) 2005-02-15
NO20034190D0 (no) 2003-09-19
US20030083271A1 (en) 2003-05-01
HRP20030761A2 (en) 2004-04-30
JP2004534006A (ja) 2004-11-11
RU2003131269A (ru) 2005-05-10
NO20034190L (no) 2003-11-19
MXPA03008589A (es) 2003-12-08
IS6958A (is) 2003-09-16
IL157909A0 (en) 2004-03-28
YU74103A (sh) 2006-05-25
PL368942A1 (en) 2005-04-04
EE200300456A (et) 2004-02-16
KR20030085035A (ko) 2003-11-01
WO2002077255A1 (en) 2002-10-03
CA2441412A1 (en) 2002-10-03
CN1509335A (zh) 2004-06-30
BR0208322A (pt) 2004-10-13
CZ20032876A3 (en) 2004-03-17
ZA200307317B (en) 2004-12-20

Similar Documents

Publication Publication Date Title
TW200510407A (en) Novel pyrrolodihydroisoquinolines as PDE 10 inhibitors
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
PL1951729T3 (pl) Pochodne pirymidyny połączone przez atom tlenu
MXPA03009840A (es) Derivados de fenilurea sustituidos con carboxamida y metodo para la produccion de los mismos como farmacos.
JO2707B1 (ar) مشتقات ثيوفين جليكوسايد جديدة, طرق تحضيرها, والادوية المحتوية على هذه المركبات واستخدامها
MY132106A (en) New pyridazin-3(2h)-one derivatives
WO2002008190A3 (de) Neue heteroaryl-derivate und deren verwendung als antitumormittel
RS20050864A (en) Novel pyridopyrazines and use thereof as kinase inhibitors
MXPA05012645A (es) Piridopirazinas novedosas y su uso como moduladores de cinasa.
EP1675552A4 (en) PREPARATION OF 1,6-DISUBSTITUTED AZABENIC ZIMIDAZOLES AS KINASE-INHIBITORS
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
WO2003106384A3 (en) NOVEL BORIC CHALCONE DERIVATIVES AND USES THEREOF
TW200745102A (en) Pyrido[2,3-d]pyrimidine derivatives, preparation thereof, therapeutic use thereof
DE69938192D1 (en) Imidazonaphthyridine
WO2003039545A3 (en) Carboline derivatives as inhibitors of ikb in the treatment of multiple myeloma and others cancers
IL165558A0 (en) N-benzoylureidocinnamate derivatives method for production and use thereof
WO2002010152A3 (de) Neue indolderivate und deren verwendung als arzneimittel
WO2004110990A3 (en) Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38
MXPA02009551A (es) Profarmacos de derivados de imidazopiridina.
WO2002030941A3 (en) Topoisomerase inhibitors
MXPA05008902A (es) Soluciones de drogas en mentol.
IL154755A0 (en) Antitumor theraphy comprising distamycin derivatives
ATE250603T1 (de) 1,8-naphthalimid imidazo(4,5,1-de)acridone mit antitumorwirkung
RS88704A (en) Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
HK1053838A1 (en) Pyrano(2,3-c)imidazo(1,2-a)pyridine derivatives for the treatment of gastrointestinal disorders